Friday, January 19, 2024 11:39:46 AM
Recent MGRX News
- MangoRx Receives Patent Notice of Allowance in Japan for Revolutionary Preventive Care Technology Acquired from Intramont Technologies • GlobeNewswire Inc. • 06/04/2024 08:00:00 PM
- MangoRx to Introduce “MOJO” Pharmaceutical Compounded Formula Featuring Enclomiphene Citrate and Pregnenolone for Treatment of Low Testosterone and Male Hormone Imbalances • GlobeNewswire Inc. • 06/04/2024 12:00:00 PM
- Mangoceuticals, Inc. Announces Completion of First Batch of Mango ED Products for Marketing and Distribution in Mexico and Latin American Markets • GlobeNewswire Inc. • 05/28/2024 12:30:00 PM
- MangoRx Engages Renown International Digital and Performance Marketing Company Crakmedia to Champion its Digital Marketing Efforts • GlobeNewswire Inc. • 05/23/2024 12:30:00 PM
- MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications • GlobeNewswire Inc. • 05/21/2024 12:30:00 PM
- MangoRx Reports Revenue Growth of 108% in Q1 2024 Fueled by Amplified Customer Acquisition and Early Market Penetration • GlobeNewswire Inc. • 05/16/2024 08:40:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 05/16/2024 05:59:25 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 05/16/2024 01:19:29 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:52:16 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/14/2024 01:00:58 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/06/2024 09:32:18 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/06/2024 08:43:00 PM
- Mangoceuticals Granted 180-Day Extension to Meet Nasdaq Minimum Bid Price Requirement and Conditional Approval of Compliance with Nasdaq’s Minimum Stockholders’ Equity Requirement • GlobeNewswire Inc. • 05/02/2024 12:00:00 PM
- Mangoceuticals Acquires Global Patent Portfolio to Revolutionize Preventive Care • GlobeNewswire Inc. • 04/25/2024 12:30:00 PM
- Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products • GlobeNewswire Inc. • 04/12/2024 12:45:00 PM
- MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment • GlobeNewswire Inc. • 03/12/2024 01:00:00 PM
- MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue Growth • GlobeNewswire Inc. • 02/20/2024 02:00:00 PM
- MANGORX AWARDS SAN FRANCISCO TEAM FREE MANGORX ED PRODUCTS FOR ONE YEAR FOLLOWING BIG GAME LOSS TO KANSAS CITY • GlobeNewswire Inc. • 02/13/2024 01:00:00 PM
- MANGORX TO OFFER THE BIG GAME’S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE… SPIRITS • GlobeNewswire Inc. • 02/06/2024 02:00:00 PM
- MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product • GlobeNewswire Inc. • 02/05/2024 01:50:00 PM
- MangoRx’s Brand and Products to be Featured by Barstool Sports in Week of Programming Around the Biggest Sports Event of the Year on February 11 • GlobeNewswire Inc. • 01/19/2024 01:00:00 PM
- Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering • GlobeNewswire Inc. • 12/15/2023 03:39:00 PM
- MANGOCEUTICALS TO INTRODUCE “PRIME”, POWERED BY KYZATREX®️ (CIII TESTOSTERONE UNDECANOATE CAPSULES), FOR AN FDA APPROVED ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT) PRODUCT • GlobeNewswire Inc. • 12/13/2023 12:30:00 PM
- Mangoceuticals Launches MangoRx Mexico Subsidiary, Paving the Way for Over-the-Counter Retail of Erectile Dysfunction Line of Products in Latin America • GlobeNewswire Inc. • 12/06/2023 01:00:00 PM
FEATURED Element79 Gold Corp Continues Fostering Local Community Engagement • Jun 4, 2024 9:08 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM
ECGI Holdings Accelerates Strategic Initiatives by Securing First of Two $125,000 Convertible Notes • ECGI • Jun 4, 2024 12:15 PM
PickleJar Debuts Nationwide Contest With Brian Kelley for Fans to Win a Three-Day Bahama Cruise • NREG • Jun 3, 2024 8:45 AM
ILUS Provides an Update on the Binding Term Sheet Signed with Actelis Networks (NASDAQ: ASNS) • ILUS • May 31, 2024 12:52 PM
Element79 Gold To Provide Summary and Update on Active Exploration Program, Community Relations at RMEC on June 4 • ELEM • May 30, 2024 1:18 PM